9,500.00

Content Details
Information on this page was last modified on : 2024/03/01 3:07:06 PM

Brilinta 90mg tablet (Ticagrelor)

(3 customer reviews)
Belongs to Category

Alternate brands of Brilinta 90mg tablet (Ticagrelor)

Brand Name Price Savings
Virata tablet 90 mg 20’s  1,086.00 You can save 8414
Anplag tablet 90 mg 20’s  1,086.00 You can save 8414
List of alternate brands

Brilinta 90mg tablet (Ticagrelor) is used to prevent stroke, heart attack and other events in people with acute coronary syndrome, meaning problems with blood supply in the coronary arteries. Brilinta 90mg tablet is now available in Pakistan. The price of Brilinta 90mg tablet is Rs. 9500 and can be purchased online in Pakistan from MedicalStore.com.pk

How it works

Brilinta 90mg tablet (Ticagrelor) prevents the platelets from forming clots. It thus helps in the prevention of heart attacks or strokes in susceptible patients.

Side effects

Major & minor side effects for Brilinta 90mg tablet (Ticagrelor)

  • Difficult and painful breathing severe
  • Tightness of chest severe
  • Blurred vision
  • Confusion
  • Dizziness when getting up suddenly from a sitting position severe
  • Fainting severe
  • Fast/irregular heart beat severe
  • Headache
  • Nervousness
  • Ringing or buzzing in the ears severe
  • Excessive sweating
  • Unusual tiredness or weakness
  • Bleeding gums severe
  • Black or Tarry stools severe
  • Unusual bleeding or bruising severe
  • Increased menstrual flow
  • Swelling of the face, arms, hands, lower legs, or feet severe
  • Bleeding from nose severe

Uses of Brilinta 90mg tablet (Ticagrelor)

What is it prescribed for?

  • Acute Coronary Syndrome

    This medicine is used to reduce the rate of stroke, heart attack, and cardiovascular death in patients with an acute coronary syndrome or history of myocardial infarction. It is used in a combination with aspirin and is considered superior to clopidogrel. It is normally given for at least 12 months following an event of an acute coronary syndrome.

Concerns

Frequently asked questions

  • Onset of action

    The effect of this medicine can be observed within 30 minutes of administration of the loading dose.

  • Duration of Effect

    The amount of time for which this medicine remains active in the body is not clinically established.

  • Safe with Alchohol?

    Interaction with alcohol is unknown. It is advisable to consult your doctor before consumption.

  • Is it habit forming?

    No habit-forming tendencies were reported.

  • Usage in pregnancy?

    This medicine is not recommended for use in pregnant women unless absolutely necessary. Your doctor will determine the best course of treatment after evaluating the potential benefits and risks associated with the use of this medicine.

  • Usage while breast-feeding?

    This medicine is not recommended for use in breastfeeding women unless absolutely necessary. All the risks and benefits should be discussed with the doctor before using this medicine. Your doctor may advise you to discontinue the drug or to discontinue breastfeeding based on your clinical condition.

When not to use?

  • Allergy

    This medicine is not recommended for use in patients with a known allergy to Brilinta 90mg tablet (Ticagrelor) or any other inactive ingredient present in the formulation.

  • Uncontrolled active bleeding

    This medicine is not recommended for use in patients with an active bleeding disorder that may be caused due to complications such as a peptic ulcer or hemorrhages in the head region due to the increased risk of worsening of the patient’s condition.

  • Intracranial bleeding

    This medicine is not recommended for use in patients with a history of bleeding inside the skull since the risk of recurrence of severe bleeding is significantly high.

Warnings

Warnings for special population
  • Pregnancy

    This medicine is not recommended for use in pregnant women unless absolutely necessary. Your doctor will determine the best course of treatment after evaluating the potential benefits and risks associated with the use of this medicine.

  • Breast-feeding

    This medicine is not recommended for use in breastfeeding women unless absolutely necessary. All the risks and benefits should be discussed with the doctor before using this medicine. Your doctor may advise you to discontinue the drug or to discontinue breastfeeding based on your clinical condition.

General Warnings
  • Other medicines

    Brilinta 90mg tablet (Ticagrelor) may interact with many other medicines and may cause severe adverse effects. Hence, it is advised that you inform the doctor about all your current medicines including any herbs and supplements before beginning treatment with this medicine.

  • Risk of bleeding

    Use of this medicine may increase the chances of bleeding, especially in patients with a history of bleeding disorders. It is advised to manage the bleeding without discontinuing the use of this medicine. Appropriate dose adjustments or replacement with a suitable alternative may be required in some cases based on the clinical condition.

  • Maintenance dose of aspirin

    This medicine is normally used in a combination with aspirin. The dose of aspirin in a combination with this medicine should not exceed 100 mg.

  • Dyspnea

    Use of this medicine may cause breathing difficulties, especially in patients with a history of dyspnea. If the symptoms of dyspnea become very severe, then the use of this medicine should be discontinued.

  • Termination of use

    Discontinuing the use of this medicine may increase the risk of heart attack, stroke, and other heart-related complications in some patients. If there is a clinical necessity to stop the use of this medicine, then the uptake of this medicine should be resumed as soon as possible.

  • Heart rhythm abnormalities

    Use of this medicine may cause heart rhythm abnormalities in some patients; the likelihood of occurrence is higher in patients with a history of heart-related complications like sick sinus syndrome, 2nd or 3rd degree AV block, bradycardia related syncope not protected by a pacemaker, etc. Additional monitoring may be required in such cases since the risk of adverse events is significantly high. Appropriate corrective measures, dose adjustments, or replacement with a suitable alternative may be necessary in some cases based on the clinical condition.

  • Liver diseases

    This medicine is not recommended for use in patients with severe impairment of liver function unless absolutely necessary. For mild to moderate impairment of liver function, this medicine may be given with appropriate dose adjustments and frequent monitoring of liver function tests.

  • Use in Children

    This medicine is not recommended for use in patients less than 18 years of age since the safety and efficacy of use are not clinically established.

  • Driving or Operating machinery

    Use of this medicine may cause blurred vision or dizziness in some patients. It is advised that you do not perform any activities such as driving a vehicle or operating machinery if you experience any of these symptoms during treatment with this medicine.

Dosage

  • Missed Dose

    Take the missed dose as soon as you remember. If it is almost time for the next scheduled dose, then the missed dose can be skipped. Do not double your dose to make up for the missed one.

  • Overdose

    Seek emergency medical treatment or contact the doctor in case of an overdose.

Interactions

Interaction with Medicines
  • Atazanavir severe
  • Phenobarbital severe
  • Dalteparin severe
  • Phenytoin severe
  • Carbamazepine severe
  • Mifepristone severe
  • Clarithromycin severe
  • Ketoconazole severe
  • Rifampicin severe
  • Apixaban severe
Disease interactions
  • severe

    This medicine should be used with caution in patients with mild to moderate liver diseases and it is not recommended for use in patients with severe liver diseases unless absolutely necessary. Regular monitoring of the liver function tests is necessary while receiving this medicine. Appropriate dose adjustments or replacement with a suitable alternative may be required in some cases based on the clinical condition.

  • moderate

    This medicine should be used with caution and monitoring in patients with a history of sick sinus syndrome, 2nd or 3rd degree AV block, or bradycardia-related syncope not protected by a pacemaker since the risk of developing a severe decrease in heart rate is significantly high. An alternative treatment option may be necessary in some cases based on the clinical condition

  • moderate

    This medicine should be used with caution in patients that experience shortness of breath. Use of this medicine may worsen the episodes of dyspnea in some cases and hence, monitoring is advised. Appropriate corrective measures, dose adjustments, or replacement with a suitable alternative may be required in some cases based on the clinical condition.

  • moderate

    This medicine should be used with caution in patients with kidney diseases due to the increased risk of severe adverse effects. Regular monitoring of kidney function tests is necessary while receiving this medicine. Appropriate dose adjustments or replacement with a suitable alternative may be required in some cases based on the clinical condition.

General Instructions

Take this medicine exactly as prescribed by the doctor. Do not take it in larger or smaller quantities than recommended. Report any heart-related adverse events to the doctor while this medicine is being taken. Ensure that the course of treatment is completed. Do not stop the use of this medicine without consulting your doctor.

Other details

  • Can be taken with or without food, as advised by your doctor
  • To be taken as instructed by doctor
  • Does not cause sleepiness

References

Additional Information:

One of the following licensed pharmacy from the nearest location will deliver Brilinta 90mg tablet (Ticagrelor). The details of the licensed pharmacy shall be shared once you request the drugs and the respective pharmacy accepts your request based on valid prescription and availability.

Want to share this information?
Facebook
Twitter
LinkedIn
Something doesn't feel right ?

Questions and Answers

There are no questions yet. Be the first to ask a question about this product.

Only registered users are eligible to enter questions

3 reviews for Brilinta 90mg tablet (Ticagrelor)

  1. moeez ullah qureshi

    moeez ullah qureshi submitted 5 stars.

  2. Mohsin Raza

    I order before also but I didn’t get until now so that’s why I rapeet order if you delivered first one then don’t deliver this one

  3. saira

    saira submitted 5 stars.

Add a review
Shopping Cart